1. Home
  2. EML vs ALDX Comparison

EML vs ALDX Comparison

Compare EML & ALDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eastern Company (The)

EML

Eastern Company (The)

HOLD

Current Price

$25.32

Market Cap

129.1M

ML Signal

HOLD

Logo Aldeyra Therapeutics Inc.

ALDX

Aldeyra Therapeutics Inc.

HOLD

Current Price

$2.07

Market Cap

136.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EML
ALDX
Founded
1858
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
129.1M
136.9M
IPO Year
1995
2014

Fundamental Metrics

Financial Performance
Metric
EML
ALDX
Price
$25.32
$2.07
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$5.50
AVG Volume (30 Days)
59.6K
2.1M
Earning Date
05-12-2026
05-01-2026
Dividend Yield
1.98%
N/A
EPS Growth
185.40
40.43
EPS
0.11
N/A
Revenue
$248,970,345.00
N/A
Revenue This Year
$19.05
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$235.55
N/A
Revenue Growth
N/A
N/A
52 Week Low
$17.61
$1.07
52 Week High
$29.91
$6.18

Technical Indicators

Market Signals
Indicator
EML
ALDX
Relative Strength Index (RSI) 54.61 53.31
Support Level $18.34 $1.49
Resistance Level $29.91 $2.27
Average True Range (ATR) 1.39 0.22
MACD -0.06 0.01
Stochastic Oscillator 37.81 46.34

Price Performance

Historical Comparison
EML
ALDX

About EML Eastern Company (The)

The Eastern Co manages industrial businesses that design, manufacture, and sell engineered solutions to the industrial market. The company manages the financial, operational, and strategic performance of its businesses to increase cash generation, operating earnings, and long-term shareholder value. It has one reportable segment: Engineered Solutions, which provides engineered solutions mainly for the commercial transportation and logistics markets. This segment offers a diverse product line of custom and standard vehicular and industrial hardware, including turnkey returnable packaging solutions, blow molds, compression latches, draw latches, hinges, camlocksaccess, mirrors, and mirror-cameras, among other products. Geographically, the group derives maximum revenue from the United States.

About ALDX Aldeyra Therapeutics Inc.

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma, and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.

Share on Social Networks: